Repair and control genes in any cell: In the area classically thought of as gene therapy, we are investing in both delivery and gene modification capabilities.
Replace any cell in the body: The convergence of stem cell biology and immunology means we have the potential to replace missing or damaged tissue in the body.
Tear down barriers to accessing our therapies: Scalable manufacturing with a focus on the cost of manufacturing, and working to align with key stakeholders will enable broader patient access to our therapies.

Sana - Hematopoietic Stem Cells - Fusogen Technology